EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Longitudinal phosphoproteomics reveals the PI3K-PAK1 axis as a potential target for recurrent colorectal liver metastases

Daigo Gunji, Yuichi Abe, Satoshi Muraoka, Ryohei Narumi, Junko Isoyama, Narumi Ikemoto, Mimiko Ishida, Akina Shinkura, Takeshi Tomonaga, Satoshi Nagayama, Yu Takahashi, Yosuke Fukunaga und 3 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.115061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Daigo Gunji und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osak…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, p21-Activated Kinases, Proteomics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiver Neoplasmsp21-Activated KinasesProteomicsPhosphatidylinositol 3-KinasesHumansCell Line, TumorAnimalsMiceFemaleMaleFluorouracilDrug Resistance, NeoplasmMice, NudePhosphoproteinsSignal TransductionNeoplasm Recurrence, Local

Stichwörter der Autor:innen

CP: Cancerchemotherapy resistancecolorectal cancer liver metastasescomputational approachesdrug repositioningphosphoproteomic dynamics

Substanzen

p21-Activated KinasesPhosphatidylinositol 3-KinasesPAK1 protein, humanFluorouracilPhosphoproteins

Autor:innen und Institutionen

  • Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan; Department of Surgery, Kyoto University Graduate Sc…
  • Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan; Immunoproteomics Laboratory, Institute for Glyco-co…
  • Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.
  • Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan; Department of Surgery, Uji-Tokusyukai Medical Center, Kyoto 611-0041, Japan.
  • Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.
  • Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.

Förderung

  • Core Research for Evolutional Science and Technology
  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science

Zitieren

APA

Gunji, D., Abe, Y., Muraoka, S., Narumi, R., Isoyama, J., Ikemoto, N., Ishida, M., Shinkura, A., Tomonaga, T., Nagayama, S., Takahashi, Y., Fukunaga, Y., Sakai, Y., Obama, K., & Adachi, J. (2024). Longitudinal phosphoproteomics reveals the PI3K-PAK1 axis as a potential target for recurrent colorectal liver metastases. Cell Reports. https://doi.org/10.1016/j.celrep.2024.115061

Vancouver

Gunji D, Abe Y, Muraoka S, Narumi R, Isoyama J, Ikemoto N, et al. Longitudinal phosphoproteomics reveals the PI3K-PAK1 axis as a potential target for recurrent colorectal liver metastases. Cell Reports. 2024. doi:10.1016/j.celrep.2024.115061

BibTeX
@article{Gunji2024,
  author = {Gunji, Daigo and Abe, Yuichi and Muraoka, Satoshi and Narumi, Ryohei and Isoyama, Junko and Ikemoto, Narumi and Ishida, Mimiko and Shinkura, Akina and Tomonaga, Takeshi and Nagayama, Satoshi and Takahashi, Yu and Fukunaga, Yosuke and Sakai, Yoshiharu and Obama, Kazutaka and Adachi, Jun},
  title = {Longitudinal phosphoproteomics reveals the PI3K-PAK1 axis as a potential target for recurrent colorectal liver metastases},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.115061}
}
Kostenlos starten →